·ù¸¶Æ¼½º°üÀý¿° ȯÀÚ¿¡¼­ ¹ß»ýÇÑ ºñÁ¤Çü ´ëÅð°ñ °ñÀýÀÇ 1¿¹
Atypical Femoral Fracture in a Patient with Rheumatoid Arthritis

´ëÇѳ»°úÇÐȸÁö 2014³â 87±Ç 2È£ p.240 ~ p.244

±è´ã(Kim Dam) - ÇѾç´ëÇб³ ·ù¸¶Æ¼½ºº´¿ø ·ù¸¶Æ¼½º³»°ú
Á¤¼Ò´ã(Jung So-Dam) - ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¼Õâ³²(Son Chang-Nam) - ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
ÃÖÁö¿µ(Choi Ji-Young) - ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
À̽ÂÈÆ(Lee Seung-Hun) - ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ ¿µ»óÀÇÇб³½Ç
±èÀ̼®(Kim Yi-Suk) - ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ Á¤Çü¿Ü°úÇб³½Ç
¼ºÀ±°æ(Sung Yoon-Kyoung) - ÇѾç´ëÇб³ ·ù¸¶Æ¼½ºº´¿ø ·ù¸¶Æ¼½º³»°ú

Abstract

Atypical femoral fractures are characterized by a subtrochanteric or diaphyseal location. Recent studies have suggested that long-term treatment with bisphosphonates might be associated with the occurrence of atypical femoral fractures. The present report describes a case involving a 60-year-old woman with left buttock pain that was unassociated with trauma. Her hip pain was initially considered to be a symptom of her underlying rheumatoid arthritis, but a plain radiography, bone scintigraphy, and magnetic resonance imaging revealed an insufficiency fracture in the lateral shaft of the left proximal femur. She had been treated with a bisphosphonate for 4.5 years because of a previous vertebral fracture. Her chronic, long-term rheumatoid arthritis and history of bisphosphonate administration were considered to be associated with the development of her atypical femoral fracture.

Å°¿öµå

Femoral fracture, Arthritis, Rheumatoid, Alendronate
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå